Inogen (INGN) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

INGN Inogen

Watchlist

10.593
+0.263+2.54%

Trading Jan 14 15:18 ET

252.30MMarket Cap-4.71P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Needham Maintains Inogen(INGN.US) With Hold Rating
Moomoo NewsJan 14 07:36 ET · Ratings
Express News | Needham Reiterates Hold on Inogento Hold
BenzingaJan 14 06:28 ET
Inogen Analyst Ratings
BenzingaJan 14 06:27 ET · Ratings
Stifel Maintains Inogen(INGN.US) With Hold Rating, Maintains Target Price $10
Moomoo NewsJan 13 20:32 ET · Ratings
Inogen's Q4 Revenue Beat Overshadowed by Lack of Guidance, Earning a Hold Rating
TipRanksJan 13 20:08 ET · Ratings
Express News | Inogen Inc: Sees FY 2024 Rev to Be in Range $334.5 Mln to $335.5 Mln
ReutersJan 13 16:02 ET

Comments

Jaguar8

Dec 30, 2024 18:43

NEWS TODAY

$Inogen (INGN.US)$
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Monday, 30th December at 8:30 am
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company's ability to market and meet the various needs of patients with chronic...

Trytosaveabit

Aug 6, 2024 15:41

Hmm

$Inogen (INGN.US)$
Second Quarter 2024 Financial Results
Second quarter total revenue increased 6.1% to $88.8 million from $83.6 million in the second quarter of 2023, primarily driven by higher demand and new customers in international and domestic business-to business sales, partially offset by lower direct-to-consumer sales and rental revenue.
Total gross margin was 48.1% in the second quarter of 2024 versus 40.7% in the comparative period in 2023. The increase was driven primarily by low...

Moomoo AI

Feb 9, 2024 05:21

Investors' belief that strong revenue growth is not on the horizon for Inogen contributes to its low P/S ratio. The company's underwhelming revenue outlook is a major factor. A change of fortune is needed to justify a higher P/S in the future.